Subscribe for Free to Receive Worldwide Academic Conference Alerts!

Conferencealert.co presents the smart web portal about information on academic conferences worldwide. Often at times, academicians/scholars and students need to attend the conferences on the interested topics for various academic purposes, but could not track them in a sequence. Fortunately, the solution lies here only by subscription of conference alerts for absolutely free of cost. The precisely drafted alerts provide relevant information associated with the conference commencing ahead. Remarkably, the subscribers can follow the conferences held in near future due to the conference alerts 2019-20 sent out early.

Header Promotion

Promotion

Event Detail

International Conference on Oncolytic Virus Therapeutics (ICOVT)



Event Serial-286472
Website http://www.conferenceonline.net/Conference/48/ICOVT/
Contact Person- Conference Coordinator
Event enquiries email address- info@conferenceonline.net
Deadline for abstracts/proposals: 2020-11-06
Organized by: Conference Online
Venue: London,  London,  United Kingdom

About Event

International Conference on Oncolytic Virus Therapeutics aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Oncolytic Viruses and Immunotherapy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Oncolytic Viruses and Immunotherapy. Oncolytic Virus is an international platform for presenting research about Virus Outbreaks, control and Therapy. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine development is thus of great importance in terms of global health. Oncolytic viruses are a novel class of anti-cancer agents which in many cases have entered clinical trials. These viruses are capable of attacking cancer cells in a distinctive manner leading to cell-specific and targeted tumor therapy.